A Safety and Efficacy of Supralimus™ Core™ Sirolimus Eluting Stent at MAX DDHV Institute
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2008-12-19
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Sahajanand Medical Technologies Limited
- Target Recruit Count
- 105
- Registration Number
- NCT00811616
- Locations
- 🇮🇳
Max Heart and Vascular Institute, New Delhi, India
Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)
Phase 4
Completed
- Conditions
- Coronary Restenosis
- Interventions
- Device: Supralimus®Device: Infinnium®Device: Milennium Matrix® (Control)
- First Posted Date
- 2008-09-15
- Last Posted Date
- 2015-11-20
- Lead Sponsor
- Sahajanand Medical Technologies Limited
- Target Recruit Count
- 280
- Registration Number
- NCT00752362
- Locations
- 🇧🇷
Hospital Meridional Intercath, Vitória, Espirito Santo, Brazil
🇧🇷Hospital Biocor, Belo Horizonte, Minas Gerais, Brazil
🇧🇷Rede D'Or de Hospitais, Rio de Janeiro, Brazil
© Copyright 2025. All Rights Reserved by MedPath